Researchers from the University of North Carolina (UNC) analyzed how the human immunodeficiency virus (HIV) attacks macrophages – a target that, up until now, was believed to have little to do with infection.
An oxycodone (Xtampza) extended-release (ER) product is the newest opioid soon to be on the market for chronic pain.
Rosacea patients are at a higher risk of developing Alzheimer’s disease and dementia, according to new research.
US birth rates show fewer teenagers are having babies--at least in states where abortion is readily available--but ethnic and racial disparities remain a challenge.
Two long-acting muscarinic antagonists got comparable results in a trial with COPD patients.
Under the threat of lawsuits, seven major commercial insurers doing business in New York will now cover direct acting antivirals for patients with HCV infection, as will NY's Medicaid program. The plans will also stop denying coverage to patients who abuse drugs or alcohol.
Patients with chronic obstructive pulmonary disease (COPD) are more likely to receive short-acting bronchodilator, oxygen therapy, and referral to a pulmonologist if they are treated by nurses and physician assistants.
As more states across the country legalize marijuana in a variety of forms the usefulness of cannabinoids as a treatment method for people with neuropathic pain remains a question that many studies have explored.
Levels of anxiety are up to three times higher in older adults with chronic obstructive pulmonary disease (COPD) than in patients without COPD.